Show simple item record

dc.contributor.authorOnonge, Sam
dc.contributor.authorKaramagi, Charles
dc.contributor.authorNakabiito, Clemensia
dc.contributor.authorWandabwa, Julius
dc.contributor.authorMirembe, Florence
dc.contributor.authorRukundo, Godfrey Zari
dc.contributor.authorJennings, Larissa
dc.date.accessioned2022-07-15T13:21:33Z
dc.date.available2022-07-15T13:21:33Z
dc.date.issued2013
dc.identifier.citationOnonge, S., Karamagi, C., Nakabiito, C., Wandabwa, J., Mirembe, F., Rukundo, G. Z., & Jennings, L. (2014). Predictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Uganda. International Journal of Gynecology & Obstetrics, 124(3), 235-239.en_US
dc.identifier.urihttp://ir.must.ac.ug/xmlui/handle/123456789/2240
dc.description.abstractObjective: To determine factors associated with an unknown HIV serostatus among pregnant women admitted in labor to Mulago Hospital, Kampala, Uganda. Methods: In total, 665 pregnant women admitted to Mulago Hospital were interviewed about their sociodemographic characteristics, obstetric history, access to prenatal care, fears regarding HIV testing, and knowledge about modes of mother-to-child-transmission (MTCT). Knowledge of the HIV serostatus was assessed by self-report and verified by prenatal card review. Results: The prevalence of unknown HIV serostatus at the time of labor was 27.1%. Factors associated with an unknown HIV serostatus included high parity (odds ratio [OR] 1.9; 95% confidence interval [CI], 1.16–3.14), preterm delivery (OR 2.60; 95% CI, 1.06–6.34), prenatal care at a private clinic (OR 12.87; 95% CI, 5.68–29.14), residence more than 5 km from the nearest prenatal clinic (OR 2.86; 95% CI, 1.18–17.9), high knowledge about MTCT (OR 0.25; 95% CI, 0.07–0.86), and fears related to disclosing the test result to the partner (OR 3.60; 95% CI, 1.84–7.06). Conclusion: The high prevalence of unknown HIV serostatus among women in labor highlights the need to improve accessibility to HIV testing services early during pregnancy to be able to take advantage of antiretroviral therapy.en_US
dc.description.sponsorshipGrant number 5R24TW00 8886 supported by the Office of the US Global Aids Coordinator, the National Institutes of Health, and the Health Resources and Service Administrationen_US
dc.language.isoen_USen_US
dc.publisherInternational Journal of Gynecology and Obstetricsen_US
dc.subjectDeliveryen_US
dc.subjectLaboren_US
dc.subjectPrevention of mother-to-child transmissionen_US
dc.subjectUnknown HIV serostatusen_US
dc.titlePredictors of unknown HIV serostatus at the time of labor and delivery in Kampala, Ugandaen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record